Equalactin Interactions
There are 33 drugs known to interact with Equalactin (polycarbophil), along with 5 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 7 are moderate, and 26 are minor.
- View all 33 medications that may interact with Equalactin
- View Equalactin alcohol/food interactions (1)
- View Equalactin disease interactions (5)
Most frequently checked interactions
View interaction reports for Equalactin (polycarbophil) and the medicines listed below.
- Abilify (aripiprazole)
- acetaminophen
- Aleve (naproxen)
- allopurinol
- alpha-lipoic acid
- amitriptyline
- amlodipine
- Aspercreme Maximum Strength Lidocaine Patch (lidocaine topical)
- Aspirin Low Strength (aspirin)
- Atarax (hydroxyzine)
- atenolol
- Axid (nizatidine)
- B-Complex with B-12 (multivitamin)
- Basaglar (insulin glargine)
- Benicar (olmesartan)
- Benicar HCT (hydrochlorothiazide / olmesartan)
- Bentyl (dicyclomine)
- bisacodyl
- Effexor XR (venlafaxine)
- Imodium (loperamide)
- levothyroxine
- lisinopril
- losartan
- metformin
- nitroglycerin
- Pepcid AC (famotidine)
- Remeron (mirtazapine)
- tizanidine
- Vitamin D3 (cholecalciferol)
- vitamin e
Equalactin alcohol/food interactions
There is 1 alcohol/food interaction with Equalactin (polycarbophil).
Equalactin disease interactions
There are 5 disease interactions with Equalactin (polycarbophil) which include:
- intestinal obstruction
- inflammatory bowel disease
- intestinal obstruction disorders
- renal dysfunction
- hypercalcemia
More about Equalactin (polycarbophil)
- Equalactin consumer information
- Compare alternatives
- Drug images
- Side effects
- Drug class: laxatives
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.